These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 19079906)
21. Curcumin and the cellular stress response in free radical-related diseases. Calabrese V; Bates TE; Mancuso C; Cornelius C; Ventimiglia B; Cambria MT; Di Renzo L; De Lorenzo A; Dinkova-Kostova AT Mol Nutr Food Res; 2008 Sep; 52(9):1062-73. PubMed ID: 18792015 [TBL] [Abstract][Full Text] [Related]
22. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Weiskirchen R; Mahli A; Weiskirchen S; Hellerbrand C Front Physiol; 2015; 6():140. PubMed ID: 25999863 [TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone: possible complications and treatment of non-alcoholic steatohepatitis (NASH). Henriksen JH; Ring-Larsen H J Hepatol; 2008 Jan; 48(1):174-6. PubMed ID: 18022724 [No Abstract] [Full Text] [Related]
24. Insulin resistance and oxidative stress: two therapeutic targets in non-alcoholic steatohepatitis. Voican CS; Perlemuter G J Hepatol; 2011 Feb; 54(2):388-91. PubMed ID: 21112115 [No Abstract] [Full Text] [Related]
25. CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance. Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA Cell Metab; 2014 Nov; 20(5):919. PubMed ID: 29665397 [No Abstract] [Full Text] [Related]
26. Correction to: Myeloid‑specific deletion of chitinase‑3‑like 1 protein ameliorates murine diet‑induced steatohepatitis progression. Kim AD; Kui L; Kaufmann B; Kim SE; Leszczynska A; Feldstein AE J Mol Med (Berl); 2023 Dec; 101(12):1627. PubMed ID: 37953339 [No Abstract] [Full Text] [Related]
27. Effect of Curcumin Nanoemulsions Stabilized with MAG and DAG-MCFAs in a Fructose-Induced Hepatic Steatosis Rat Model. Agame-Lagunes B; Grube-Pagola P; García-Varela R; Alexander-Aguilera A; García HS Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33917706 [TBL] [Abstract][Full Text] [Related]
28. Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies. Arozal W; Louisa M; Soetikno V Front Cardiovasc Med; 2020; 7():82. PubMed ID: 32435657 [TBL] [Abstract][Full Text] [Related]
29. Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper. Antonucci L; Porcu C; Iannucci G; Balsano C; Barbaro B Nutrients; 2017 Oct; 9(10):. PubMed ID: 29057834 [TBL] [Abstract][Full Text] [Related]
30. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans. Inzaugarat ME; De Matteo E; Baz P; Lucero D; García CC; Gonzalez Ballerga E; Daruich J; Sorda JA; Wald MR; Cherñavsky AC PLoS One; 2017; 12(3):e0172900. PubMed ID: 28257515 [TBL] [Abstract][Full Text] [Related]
31. Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system. Lee J; Jo DG; Park D; Chung HY; Mattson MP Pharmacol Rev; 2014 Jul; 66(3):815-68. PubMed ID: 24958636 [TBL] [Abstract][Full Text] [Related]